You are here

  • Home
  • Archive
  • Volume 60, Issue 6
  • Association of Crohn's disease-associated NOD2 variants with intestinal failure requiring small bowel transplantation and clinical outcomes

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Association of Crohn's disease-associated NOD2 variants with intestinal failure requiring small bowel transplantation and clinical outcomes
  1. M Janse1,2,
  2. R K Weersma1,
  3. D L Sudan3,
  4. E A M Festen1,2,
  5. C Wijmenga2,
  6. G Dijkstra1,
  7. D Mercer4
  1. 1Department of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands
  2. 2Department of Genetics, University Medical Center Groningen, Groningen, The Netherlands
  3. 3Department of Abdominal Transplant Surgery, Duke University Medical Center, Durham, USA
  4. 4Department of Surgery, University of Nebraska Medical Center, Omaha, Nebraska, USA
  1. Correspondence to Dr RK Weersma, Department of Gastroenterology and Hepatology, University Medical Center Groningen, PO Box 30001, 9700 RB Groningen, The Netherlands; R.K.Weersma{at}int.umcg.nl

https://doi.org/10.1136/gut.2009.196238

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In the past decade intestinal transplantation has evolved to a viable option in the treatment of short bowel syndrome, especially for patients who have developed life-threatening complications attributable to their intestinal failure and/or long-term total parental nutrition therapy.1 Technical improvements, novel immunosuppressive agents and increased clinical experience have contributed to an improvement in intestineal transplant graft and patient survival. One-year graft and patient survival are nowadays both estimated at 80%.2 3

    Despite these recent advances, rejection resulting in failure of the graft still remains a problem causing significant patient morbidity and mortality. Identifying involved pathogenetic mechanisms might make it possible to predict or eventually prevent intestinal graft failure or rejection.

    We would like to respond to the interesting study by Fishbein et al recently published in this journal.4 The authors point out the …

    View Full Text

    Footnotes

    • Funding RW is supported by a clinical fellow grant from the Netherlands Organization for Scientific Research (NWO). CW is supported by a VICI grant from the Netherlands Organization for Scientific Research (NWO). GD is supported by a clinical fellow grant from the Netherlands Organization for Scientific Research (NWO). Other Funders: Netherlands Organization for Scientific Research (NWO).

    • Competing interests None.

    • Ethics approval This study was conducted with the approval of the University of Nebraska Medical Center, Omaha, Nebraska, USA.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    Linked Articles

    • PostScript
      Authors' response
      Thomas M Fishbein Michael Zasloff
      Gut 2011; 60 878-879 Published Online First: 11 Feb 2011. doi: 10.1136/gut.2010.220855